#StokeTx just showed us the future & will open the SYNGAP1 meeting #S10e83

I am #StokedAboutStoke BW Press Release with Link to their presentation: https://www.businesswire.com/news/home/20221114005268/en/Stoke-Therapeutics-Reports-Third-Quarter-Financial-Results-and-Provides-Business-Updates Stoke announced partnership with Acadia in Episode 43 of Syngap10… https://www.youtube.com/watch?v=jElXobgYfCQ Register for our meeting on December 1 in Nashville: https://secure.givelively.org/event/syngap-research-fund-incorporated/syngap1-conference-2022-charting-our-rare-disease-treatment-path Further reading: STOK Stock https://www.google.com/finance/quote/STOK:NASDAQ?window=1M Recent paper on ASOs: https://www.karger.com/Article/Pdf/517686 Dr. Kimberly Parkerson of Stoke Therapeutics offers an update on their BUTTERFLY observational study as well as their MONARCH and SWALLOWTAIL studies https://www.youtube.com/watch?v=xHCYFDSwf-o This is a podcast: subscribe to and rate this 10 minute #podcast #SYNGAP10 here https://www.syngapresearchfund.org/syngap10-podcast Apple podcasts: https://syngap.fund/10a  Episode 83 of #Syngap10 - November 22,  2022 #Syngap #SYNGAP1 #epilepsy #autism #intellectualdisability #id #anxiety #raredisease #epilepsyawareness #autismawareness #rarediseaseresearch #SynGAPResearchFund #CareAboutRare #PatientAdvocacy #GCchat #Neurology